Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001702447-20-000011
Filing Date
2020-04-22
Accepted
2020-04-22 19:35:00
Documents
2
Period of Report
2020-04-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 7776
2 LPOA lpoasp.txt EX-24 4160
  Complete submission text file 0001702447-20-000011.txt   13459
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Patel Samir Rashmikant (Reporting) CIK: 0001702447 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-49908 | Film No.: 20808910